CPHI 2024 in Milan was a great success for us and a significant milestone in the further development of our business activities. As every year, we were there with an impressive booth and a highly motivated crew.
The entire event was marked by intensive customer discussions and valuable encounters. Our highly motivated Business Development team had the opportunity to deepen many existing partnerships while also making exciting new connections that offer promising prospects for the future.
A special highlight of the week was the customer event on Tuesday evening. In a relaxed atmosphere, we were able to engage in open discussions with long-term partners and new prospects, sharing ideas and gaining valuable insights into future needs and trends in the industry. The positive response to this evening reinforces our approach to fostering close relationships with our clients not only on a business level but also on a personal one.
The only thing that didn't cooperate was the weather. Especially on the first day of the event, we got completely drenched on the way there, and some were glad they packed extra clothes. 😊
We are already looking forward with great anticipation to CPHI 2025 in Frankfurt, where we will once again have the opportunity to strengthen our global partnerships and discover new business opportunities.
We thank everyone who made CPHI 2024 an unforgettable experience and look forward to seeing you in Frankfurt 2025!
Â
Best regards,
Benjamin Spitteler, Sales Director BU Pharma
Visit us at the CPHI in Milan, October 8-10, 2024
One of the largest pharmaceutical trade fairs in Europe is about to begin again, and as always, we will be there with our booth.
Visit us in Hall 7, Booth No. 7D74, and let's talk about future projects.
We look forward to hearing from you.
Your FRIKE Pharma Team
Scale-up to a new level
Whereas it was previously possible for air inclusions or insufficient homogenisation to impair the tests, the new Mini offers the full range of possibilities of a production mixer. This means that reliable data is already at a new level during development for later scale-up.
This puts FRIKE in a position to support new development projects even more competently, as the new Mini is a mixer of the latest generation. It has a high-shear homogeniser with a circuit that reflects all the dosing applications of a large-scale plant. In addition, the mixer has a memory that continuously logs the parameters travelled. This enables exact comparisons of the tests carried out.
Ultimately, the fact that the new Becolab Mini is the first qualified system of its kind at FRIKE is a decisive factor for us. It can be used to prepare small quantities under GMP production conditions, which can be used in clinical trials, for example. It has already passed its baptism of fire with the first test batches, and the first projects under GMP conditions are under discussion.
What is the role of the person with technical responsibility?
«Medicines are regulated by the authorities, so they are subject to high quality requirements and must be safe for patients. The person with technical responsibility has a bridging function between the regulatory requirements in the manufacture of medicinal products and the internal implementation of these regulations. This ensures that regulatory requirements are also applied in the company and that all products meet the high quality requirements. In this context, the person with technical responsibility also acts as an interface between the authorities and the company.»
Why did you choose the FRIKE GROUP as your new employer?
«With around 300 employees, the FRIKE GROUP is one of the largest contract manufacturers in Switzerland. I appreciate being part of the set-up of a large manufacturer with a broad product range and lots of interesting products, as it means exciting projects and challenging tasks. At the same time, I like the informal working environment of FRIKE PHARMA AG, as a small company. Thanks to the manageable size of the company, my tasks are very varied and range from team management to the implementation of the GMP guidelines and the release of medicinal products as the person with technical responsibility. That won me over, and I’m looking forward to taking on many new challenges.»